Vaccine Therapy in Treating Patients With Non-Small Cell Lung Cancer (NSCLC) Stages IIIB/IV

Clinical trial NCT00516685 · TERMINATED

Trial details

NCT number: NCT00516685
Sponsor: Bioven Sdn. Bhd.
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Non-small-cell Lung Cancer (NSCLC) Stage IIIb/IV

Start date: 2007-07-01
Enrollment: 230

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.